Japan Joins Fight Against Neglected Diseases
Monday, June 3, 2013
Japan is joining global efforts to contain malaria, tuberculosis, and a variety of tropical diseases in a big way. A recently formed public-private partnership will on Saturday formally announce agreements to screen tens of thousands of drug candidates from Japanese private and public sector compound libraries for treatments for illnesses that primarily afflict the poor in developing countries.
The 11 initial agreements are the first fruits of a recently formed public-private Global Health Innovative Technology Fund (GHIT Fund). It was set up in April and brings together Japan’s foreign affairs and health and welfare ministries, a consortium of five pharmaceutical companies, and the Bill & Melinda Gates Foundation. The Japanese government is putting up a bit over one-half of the $100 million that is committed to GHIT over the next 5 years; the drugmakers and the Gates Foundation are contributing the rest. Funding could increase if more companies join the consortium, says BT Slingsby, the fund’s CEO and executive director.
- Health Care